Bothell, WA, United States of America

Nicole Okeley

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Nicole Okeley

Introduction

Nicole Okeley is a prominent inventor based in Bothell, WA (US), known for her significant contributions to the field of biotechnology. With a total of three patents to her name, she has made remarkable strides in developing innovative solutions for cancer treatment and drug delivery systems.

Latest Patents

One of her latest patents is titled "Selective drug release from internalized conjugates of biologically active compounds." This invention focuses on conjugates of biologically active compounds that include a sequence of amino acids with a tripeptide. This tripeptide allows for selective cleavage by tumor tissue homogenate, facilitating the release of free drugs and improving biodistribution into tumor tissues compared to normal tissues. Another notable patent is "T cells with reduced surface fucosylation and methods of making and using the same." This patent outlines methods for producing T cells with reduced surface fucosylation, which can be utilized in adoptive cell therapy, particularly for cancer treatment.

Career Highlights

Throughout her career, Nicole Okeley has worked with leading companies in the biotechnology sector, including Seagen Inc. and Seattle Genetics, Inc. Her work has been instrumental in advancing therapeutic strategies that target cancer cells more effectively.

Collaborations

Nicole has collaborated with notable professionals in her field, including Noah Bindman and Peter Senter. These collaborations have contributed to her innovative research and development efforts.

Conclusion

Nicole Okeley's work exemplifies the impact of innovation in biotechnology, particularly in cancer treatment and drug delivery. Her patents reflect her commitment to improving therapeutic outcomes for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…